Accuracy of PET/CT in characterization of solitary pulmonary lesions

Journal of Nuclear Medicine

Volumn 48, Issue 2, 2007, Pages 214-220

  Kim, Shanna K ^a   Allen Auerbach, Martin ^a   Goldin, Jonathan ^b   Fueger, Barbara J ^a   Dahlbom, Magnus ^a   Brown, Matthew ^b   Czernin, Johannes ^a   Schiepers, Christiaan ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

18F FDG; Lung cancer; PET CT; SPN

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LUTETIUM; LUTETIUM OXYORTHOSILICATE; SILICATE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; ADULT; AGED; ANATOMY; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; GRANULOMA; HAMARTOMA; HUMAN; HUMAN TISSUE; INFECTION; INFLAMMATION; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; LEAN BODY WEIGHT; LUNG NODULE; LUNG NON SMALL CELL CANCER; MALE; MALIGNANT NEOPLASTIC DISEASE; METABOLISM; NEUROENDOCRINE TUMOR; PAROTID GLAND CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGIST; RATING SCALE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; IMAGE PROCESSING; LUNG DISEASE; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; ROC CURVE; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34047216935     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Henschke CI, Yankelevitz D, Westcott J, et al. Work-up of the solitary pulmonary nodule: American College of Radiology - ACR Appropriateness Criteria. Radiology. 2000;215(suppl):607-609.
2. Tan BB, Flaherty KR, Kazerooni EA, Iannettoni MD. The solitary pulmonary nodule. Chest. 2003;123(1 suppl):89S-96S.
3. Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075-1084.
4. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.
5. Baldwin DR, Eaton T, Kolbe J, et al. Management of solitary pulmonary nodules: how do thoracic computed tomography and guided fine needle biopsy influence clinical decisions? Thorax. 2002;57:817-822.
6. Bury T, Dowlati A, Paulus P, et al. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging. Eur Respir J. 1996;9:410-414.
7. Hartman TE. Radiologic evaluation of the solitary pulmonary nodule. Radiol Clin North Am. 2005;43:459-465.
8. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med. 2003;348:2535-2542.
9. Gambhir SS, Shepherd JE, Shah BD, et al. Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol. 1998;16:2113-2125.
10. Shah SK, McNitt-Gray MF, De Zoysa KR, et al. Solitary pulmonary nodule diagnosis on CT: results of an observer study. Acad Radiol. 2005;12:496-501.
11. Gurney JW. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory. Radiology. 1993;186:405-413.
12. Gurney JW, Lyddon DM, McKay JA. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. Radiology. 1993;186:415-422.
13. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001;285:914-924.
14. Halpern BS, Dahlbom M, Quon A, et al. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. J Nucl Med. 2004;45:797-801.
15. Hillman BJ. Economic, legal, and ethical rationales for the ACRIN national lung screening trial of CT screening for lung cancer. Acad Radiol. 2003;10:349-350.
16. Hillman BJ. ACRIN: lessons learned in conducting multi-center trials of imaging and cancer. Cancer Imaging. 2005;5(suppl):S97-S101.
17. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847-850.
18. Yankelevitz DF, Gupta R, Zhao B, Henschke CI. Small pulmonary nodules: evaluation with repeat CT - preliminary experience. Radiology. 1999;212:561-566.
19. Hickeson M, Yun M, Matthies A, et al. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Eur J Nucl Med Mol Imaging. 2002;29:1639-1647.
20. 18F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Eur J Nucl Med Mol Imaging. 2004;31:1231-1236.
21. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500-2507.
22. 18F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med. 2006;47:426-431.
23. Schiepers C, Blatt SA, Changlai SP, et al. Characterization of solitary pulmonary nodules/masses: clinical experience under the new reimbursement policy [abstract]. J Nucl Med. 1999;40(suppl):56P.
24. Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J. FDG-PET imaging in lung cancer: How sensitive is it for bronchioloalveolar carcinoma? Eur J Nucl Med Mol Imaging. 2002;29:1166-1173.